Globus Medical Inc (GMED) stock
Close on Nov 13, 2026Market cap $9.69BP/E 17.7Yield –
Globus Medical Inc grew revenue 13.4% to $3.14B over the twelve months to Sep 30, 2026. Operating income rose 83.3% to $679.71M, moving the operating margin from 13.4% to 21.6%. Free cash flow was $766.55M, up 32.3% from a year earlier. At the latest close the market valued the company at $9.69B, 17.7 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $9.69B
- P/E ratio
- 17.7
- Price to sales
- 3.08
- Price to book
- 2.02
- Dividend yield
- –
- Free cash flow yield
- 7.91%
Fundamentals
- Revenue
- $3.14B
- Net income
- $557.64M
- EPS, diluted
- $4.07
- Free cash flow
- $766.55M
- Book value per share
- $35.26
- Diluted shares
- 136M
Trading
- Next earnings
- Feb 23, 2027 (estimated, during market hours)
- Previous close
- $72.30
- Open
- $72.75
- Day's range
- $71.72 – $73.45
- Volume
- 1,549,142
- Average volume (20 days)
- 2,008,841
- Index membership
- S&P MidCap 400, Russell 1000 (since Jun 2020), Russell 3000
- Beta (5 years)
- 0.97
- 52-week range
- $70.39 – $101.40
- RSI (14 days)
- 41.7
- Volatility (1 year)
- 38.4%
- Relative volume
- 0.96×
- WACC
- 10.0%
On 2 of our idea lists: Undervalued and financially sound, Fallen quality
Index membership is inferred from the holdings of funds that track each index (IJH, SPMD, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2012, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | GMED | S&P 500 | Difference | GMED per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -5.5% | -3.0% | −2.4 pts | ||
| 3 months | -16.1% | -2.8% | −13.3 pts | ||
| Year to date | -17.4% | +11.5% | −28.9 pts | ||
| 1 year | -14.1% | +13.5% | −27.6 pts | ||
| 3 years | +64.7% | +77.7% | −13.0 pts | +18.1% | +21.1% |
| 5 years | -2.2% | +72.6% | −74.8 pts | -0.5% | +11.5% |
| 10 years | +236.3% | +308.2% | −71.8 pts | +12.9% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Globus Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About Globus Medical
Surgical & Medical Instruments & Apparatus
Globus Medical, Inc. develops and commercializes healthcare solutions designed to treat musculoskeletal disorders and improve patient quality of life. The company operates through two primary product categories: Musculoskeletal Solutions and Enabling Technologies. Its offerings include spinal implants, motion preservation devices, regenerative biologics, orthopedic trauma hardware, joint replacement systems, and spinal cord stimulation therapies for chronic pain management. Globus also provides intraoperative neuromonitoring services and advanced surgical systems comprising robotic guidance, imaging platforms, navigation headsets, and surgical planning software. The company primarily serves surgeons, physicians, ambulatory surgery centers, and hospitals.
Company profile, executives and historyGlobus Medical stock: common questions
What is Globus Medical's stock price?
GMED closed at $72.14 on Nov 13, 2026, down 0.22% on the day. Over the past 52 weeks it traded between $70.39 and $101.40.
What is Globus Medical's market cap?
Globus Medical was worth $9.69B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is GMED's P/E ratio?
GMED trades at 17.7 times earnings, based on diluted earnings per share of $4.07 over the twelve months to Sep 30, 2026.
How much revenue does Globus Medical make?
Globus Medical reported revenue of $3.14B for the twelve months to Sep 30, 2026, up 13.4% from a year earlier.
Does Globus Medical pay a dividend?
No. Globus Medical has not paid a cash dividend over the last twelve months.
When does Globus Medical report earnings next?
Globus Medical is expected to report Q4 FY2026 results on Feb 23, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has GMED stock performed over the past year?
Including dividends, GMED returned -14.1% over the past year, against +13.5% for the S&P 500.
How many GMED shares are sold short?
9M shares were sold short at the latest FINRA report, 8.57% of the float, or 8.1 days of average trading volume.
Who are Globus Medical's competitors?
Companies most similar to Globus Medical by business, industry and size include MMED, IART, TFX, ICUI, OFIX.
See a number that looks wrong?